Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Trade Sale

Woodford loses touch with Ultrahaptics
Woodford Investment Management has reportedly reaped $24.1m on its 20% stake in University of Bristol's Ultrahaptics.
GraphPad scribbles down SnapGene
SnapGene, a molecular biology documentation spinout of UChicago, has been acquired by scientific data analysis tool provider GraphPad Software.
Freiburg celebrates Cytena exit
Cell culturing technology Cellink has bought University of Freiburg's single-cell dispensing spinout Cytena for almost $34m.
Aquinox combines with Washington’s Neoleukin
UW-founded cancer immunotherapy developer Neoleukin Therapeutics will merge with Aquinox in an all-share deal giving the spinout's shareholders roughly 38.6% equity in the new company.
Ford receives Quantum Signal
Quantum Signal has been bought by Ford after two decades of quietly producing technologies for robotic applications including autonomous driving.
VMware vies for Uhana acquisition
Telstra Ventures looks set to exit Stanford spinout Uhana in an an acquisition of undisclosed size by VMware.
Microsoft tames BlueTalon for acquisition
Microsoft has bought big data access control software developer BlueTalon, which had raised approximately $26m from investors including Stanford-StartX Fund.
Kinectrics connects with Gnosys Global
Kinectrics has bought University of Surrey's Gnosys Global in a bid to extend its global presence and unlock the potential of a combined product portfolio.

Other News

Daily deal net: July 18, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Amal advances to $365m acquisition
Boehringer Ingelheim will pay a total of up to $365m to acquire its venture fund's portfolio company Amal Therapeutics, an immunotherapy spinout of University of Geneva.
Roche’s Spark acquisition hits delay
The deadline for Roche’s $4.3bn purchase of CHOP's gene therapy developer Spark has been postponed until April 2020 amid regulatory scrutiny and pending lawsuits.
PRG acquires Metalysis
Power Resources Group has bought University of Cambridge-founded metal power producer Metalysis, which had plunged into administration last month.
ConnectM moves into Keen Home
ConnectM Technology has acquired the smart vent maker for an undisclosed sum in a deal that handed an exit to NYU Innovation Fund.
Illuminate Education coaches FastBridge Learning
FastBridge Learning spun out of University of Minnesota in 2015 and has been picked up by edtech firm Illuminate Education.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
Big deal: Roche derives MS treatment
Versant's unusual build-to-buy model has resulted in Roche acquiring a target for MS based on UCSF research and the venture firm launching a new spinout, Pipeline Therapeutics.
test reg

Login